Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Report - Six months to 30 June 2010

27th Sep 2010 07:00

RNS Number : 3173T
CareCapital Group plc
27 September 2010
 

 

 

 

 

 

CareCapital Group Plc

("CareCapital" or "the Group")

Interim Report for the Six Months to 30 June 2010

 

CareCapital Group Plc (AIM: CARE), a healthcare real estate developer and investor in the UK and Germany, is pleased to announce its interim report for the six months to 30 June 2010.

 

Highlights

·; Group rental income down 35% to £1.1m (HI 2009: £1.6m) following disposal of UK portfolio

·; Adjusted diluted Net Asset Value ("NAV") per share* 12.2p (H1 2009: 18.5p)

·; Disposal of UK portfolio for £23.5m to PHP in February 2010

·; Loss before tax of £2m (H1 2009 Profit: £0.9m)

·; Development pipeline in the UK and Germany with a combined value of £42.7m

*Adjusted diluted net asset per share - excludes deferred tax on property portfolio revaluation. Calculated on a similar basis for 2009.

 

 

 

 

 

 

 

For further information, please contact:

CareCapital Group Plc Daniel Stewart & Co. Plc Tavistock Communications

Paul Stacey, Chief Executive

Clive Hyman, Finance Director

Oliver Rigby, Corporate Finance

 

Simon Hudson

Paul Young

 

Tel: 020 7034 1949 Tel: 020 7776 6550 Tel: 020 7920 3150

[email protected]

[email protected]

[email protected]

[email protected]

[email protected]

 

 

 

 

 

 

 

 

Chairman's Statement - six months to 30 June 2010.

 

 

I am pleased to report on the financial results for the CareCapital Group for the six month period to 30th June 2010.

 

The Group's principal activities are the development of and investment in medical office buildings and other healthcare related real estate in the UK and Germany.

 

As I reported in my statement introducing the 2009 Annual Report we disposed of a portfolio of 14 medical office buildings and ancilliary pharmacies etc in February 2010 and completed in March the development of our second medical office building in Adlershof, South East Berlin, in May. This building of 4,000 sq m is 90% tenanted and it is anticipated the remaining space will be let within the next few weeks.

 

These significant events during the six month period to 30 June 2010 mean that direct comparison between these financial results and those previously reported does not properly reflect the Group's progress.

 

At 30 June 2010 the Group's investment properties and developments in progress were valued at

£35.1m (31.12.09:£60m; 30.6.09 £57.6m). Adjusted diluted Net Asset Value per share (which excludes deferred tax on property revaluations) was 12.2p at 30 June 2010; (15.5p at 31.12.09). Costs associated with the sale of the UK medical centres, as reported above, including redemption penalties incurred on the repayment of the senior debt have been written off in the period. Group rental income for the six months under review was £1.1m; (2009: £1.6m.)

 

In the UK construction works started on the project in Coventry in August and it is anticipated works will commence on site for the West Wirral project in late October. Progress continues on the rest of the medical centre development programme.

 

In addition, as announced in August, significant steps have been taken in progressing the proton therapy development initiative through Proton Therapy Global Inc ("PTG") in which CareCapital has a 25% stake. At the time of writing this report PTG has entered into letters of intent with four major healthcare institutions in the US and one in the UK. A further seven potential projects are under discussion.

 

 

I remain convinced that the development of, and investment in, medical office buildings remains one of the most stable long term property related activities and that this will continue to be the case for the foreseeable future.

 

 

 

 

 

Dr Michael Sinclair,

Chairman

27th September 2010

 

 

 

 

 

 

 

 

 

 

 

CareCapital Group Plc

Consolidated statement of comprehensive income for the six months ended 30 June 2010

Six months

Six months

Year

ended

ended

ended

30-Jun

30-Jun

31-Dec

2010

2009

2009

Unaudited

Unaudited

Audited

Notes

£

£

£

Revenue

1,119,528

1,596,719

3,414,698

Cost of sales

(200,768)

(203,817)

(455,296)

Gross profit

918,760

1,392,902

2,959,402

Administrative expenses

(1,005,945)

(939,268)

(1,808,043)

Impairment of goodwill

-

-

(1,751,960)

Loss on disposal of assets

(279,635)

-

-

Net gain /(loss) on fair value adjustment

-

-

596,807

Development costs written off

-

130,511

(502,032)

Operating profit / (loss)

(366,820)

584,145

(505,826)

Finance income

149

676

4,303

Finance costs

(1,655,868)

(1,464,826)

(2,963,463)

Change in fair value of financial instruments

-

-

-

Net finance costs

(1,655,719)

(1,464,150)

(2,959,160)

(Loss) / profit before tax

(2,022,539)

(880,005)

(3,464,986)

Taxation

-

-

1,696,466

(Loss) / Profit on ordinary activities after taxation

(2,022,539)

(880,005)

(1,768,520)

(Loss) / Profit for the period

 - attributable to equity shareholders

(2,002,462)

(905,825)

(1,903,049)

 - attributable to minority interests

20,077

25,820

134,529

(2,022,539)

(880,005)

(1,768,520)

Other Comprehensive Income

 

Exchange differences on translating foreign operations

(554,792)

(960,581)

(648,614)

Total comprehensive loss for the year

(2,577,331)

(880,005)

(2,417,134)

Total comprehensive income / (loss) attributable to :

- Equity shareholders

(2,541,929)

(1,835,362)

(2,486,802)

- Non controlling interest

(35,402)

(5,224)

69,668

(2,577,331)

(1,840,586)

(2,417,134)

Loss per Ordinary Share

(2.64)p

(1.15)p

(2.48)p

Basic and diluted - total

76,754

76,754

76,754

Weighted average number of shares ('000)

 

 

 

 

 

 

 

CareCapital Group Plc

Consolidated statement of financial position at 30 June 2010

As at

As at

As at

30 June

31 December

30 June

2010

2009

2009

Unaudited

Audited

Unaudited

£

£

£

Non - current assets

Intangible assets

-

1,751,959

Investment properties

31,143,199

55,982,399

49,367,932

Development properties

3,984,188

4,074,198

8,236,752

Leasehold improvements

68,997

73,908

75,003

Plant and equipment

35,835

47,199

62,247

35,232,219

60,177,704

59,493,894

Current assets

Trade and other receivables

477,550

512,571

314,274

Cash and cash equivalents

13,082

268,573

178,216

490,632

781,144

492,490

35,722,851

60,958,848

59,986,384

Total assets

Current liabilities

Trade and other payables

(1,327,501)

(2,453,857)

(2,785,647)

Borrowings, including finance leases

(3,475,329)

(9,207,414)

(4,609,067)

Derivative financial instruments

-

-

-

Total Current Liabilities

(4,802,830)

(11,661,271)

(7,394,713)

Non - current liabilities

Borrowings, including finance leases

(21,565,485)

(37,376,534)

(38,408,437)

Deferred tax provision

(406,954)

(406,954)

(2,103,420)

(21,972,439)

(37,783,488)

(40,511,857)

(26,775,269)

(49,444,759)

(47,906,571)

Total liabilities

8,947,582

11,514,089

12,079,813

Net assets

Equity

Share capital

767,541

767,541

767,541

Share premium account

1,397,500

1,397,500

1,397,500

Share option reserve

423,078

412,254

401,430

Reverse acquisition reserve

11,038,204

11,038,204

11,038,204

Exchange movements reserve

(639,662)

(140,349)

(486,133)

Profit and Loss account

(4,249,134)

(2,206,518)

(1,209,294)

Equity shareholders interest

8,737,527

11,268,632

11,909,248

Non controlling interest

210,055

245,457

170,565

Total equity

8,947,582

11,514,089

12,079,813

 

 

 

 

 

CareCapital Group Plc

Consolidated statement of changes in equity for the six months ended 30 June 2010

Share

Share

Share

Reverse

Exchange

Profit and

Equity

Minority

Total

rate

capital

premium

options

acquisition

movement

loss account

Shareholder

Interest

reserve

reserve

reserve

Interest

£

£

£

£

£

£

£

£

£

Balance at

1 January 2009

767,541

1,397,500

390,606

11,038,204

443,404

(303,469)

13,733,786

175,789

13,909,575

Exchange rate movement

-

-

-

-

(929,537)

-

(929,537)

(31,044)

(960,581)

Loss for the period

-

-

-

-

-

(905,826)

(905,826)

25,820

(880,005)

Total comprehensive

income

-

-

-

-

(929,537)

(905,826)

(1,835,363)

(5,224)

(1,840,586)

Share based payment

 - employee services

-

-

10,824

-

-

-

10,824

-

10,824

Balance at

30 June 2009

767,541

1,397,500

401,430

11,038,204

(486,133)

(1,209,294)

11,909,248

170,565

12,079,813

Balance at

30 June 2009

767,541

1,397,500

401,430

11,038,204

(486,133)

(1,209,294)

11,909,248

170,565

12,079,813

Exchange rate movement

-

-

-

-

345,784

-

345,784

(33,817)

311,967

Loss for the period

-

-

-

-

-

(997,224)

(997,224)

108,709

(888,515)

Total comprehensive

income

-

-

-

-

345,784

(997,224)

(651,440)

74,892

(576,548)

Share based payment

 - employee services

-

-

10,825

-

-

-

10,825

-

10,825

costs of raising finance

-

-

-

Balance at

31 December 2009

767,541

1,397,500

412,255

11,038,204

(140,349)

(2,206,518)

11,268,633

245,457

11,514,090

Balance at

1 January 2010

767,541

1,397,500

412,255

11,038,204

(140,349)

(2,206,518)

11,268,633

245,457

11,514,090

Exchange rate movement

-

-

-

-

(499,313)

-

(499,313)

(55,479)

(554,792)

Loss for the period

-

-

-

-

-

(2,042,616)

(2,042,616)

20,007

(2,022,539)

Total comprehensive

income

-

-

-

-

(499,313)

(2,042,616)

(2,541,929)

(35,402)

(2,577,331)

Share based payment

 - employee services

-

-

10,824

-

-

-

10,824

-

10,824

Balance at

30 June 2010

767,541

1,397,500

423,078

11,038,204

(639,662)

(4,249,134)

8,737,527

210,055

8,947,582

 

 

 

CareCapital Group Plc

Consolidated statement of cash flows for the six months ended 30 June 2010

Six months

Six months

Year

ended

ended

ended

30 June

30 June

31 December

2010

2009

2009

Unaudited

Unaudited

Audited

£

£

£

Cash flows from operating activities

(Loss) / Profit after taxation

(2,022,988)

(880,005)

(1,769,520)

Adjustments

Taxation

-

-

(1,696,466)

Change in fair value of financial instruments

-

-

-

Finance costs

885,747

1,464,826

2,963,463

Finance income

(149)

(676)

(4,303)

Unrealised net revaluation gains on investment properties

-

(130,511)

(596,807)

Impairment of goodwill

-

-

1,751,959

Depreciation

14,207

13,660

33,132

Write off of development properties

22,482

69,649

502,032

Share based payments

10,824

10,824

21,648

Cash flows from operations before changes in working capital

(1,089,877)

547,767

1,206,138

Change in trade and other receivables

34,970

150,907

(47,389)

Change in trade and other payables

(1,126,355)

890,256

556,477

Cash (used) / generated from operations

(2,181,262)

1,588,930

1,715,226

Interest paid

(825,965)

(1,252,236)

(2,457,309)

Cash flows from operating activities

(3,007,227)

336,694

(742,083)

Cash flows from investing activities

Sale of investment property

23,248,860

-

-

Capital expenditure on development properties

(791,775)

(4,825,697)

(6,305,031)

Capital expenditure on leasehold improvements

-

-

(3,815)

Purchase of plant and equipment

-

(13,037)

(13,199)

Profit from sale of developed properties

 280,935

-

-

Interest received

149

676

4,303

Cash flows from investing activities

22,738,169

(4,838,058)

(6,317,742)

Cash flows from financing activities

New mortgage loans raised (Net)

 953,362

2,590,777

4,446,523

Repayment of loans

(21,326,542)

(366,454)

(823,382)

Directors' loan (net of costs)

28,500

-

300,000

Other short term loans

950,000

Cash flows from financing activities

(20,344,680)

2,224,323

4,873,141

Net decrease in cash and cash equivalents

(613,738)

(2,277,041)

(2,186,684)

Cash and cash equivalents at 1 January

268,573

2,455,257

2,455,257

Cash and cash equivalents at closing

(345,165)

178,216

268,573

Comprising:

 - Cash and cash equivalents

13,082

178,216

268,573

 - Bank overdrafts

(358,247)

-

-

 - Total

(345,165)

178,216

268,573

 

 

 

 

 

 

CareCapital Group Plc

 

Notes to the accounts (Unaudited)

 

1. Basis of preparation

 

The interim report of the Groups results for the six months ended 30 June 2010 was approved by the Board on 27th September 2010.

 

The interim financial information has not been audited and does not constitute statutory accounts as defined under section 435 of the Companies Act 2006.

 

The interim financial statements have been prepared in accordance with applicable accounting standards and are consistent with those accounting policies adopted in the consolidated statutory accounts of CareCapital Group Plc for the year ended 31 December 2009, prepared under IFRS as adopted in the EU. The auditors' report on those accounts, which have been filed with the Registrar of Companies, was unqualified but did contain an Emphasis of Matter with respect of the ability of the Company and the Group to continue as a going concern. The auditors' report did not contain a statement under section 498(2) or 498 (3) of the Companies Act 2006.

 

In the Group's annual report and accounts, the Directors stated that additional working capital would be required to fund progress on several development projects, a number of funding options had been reviewed and negotiations were progressing to secure the required finance. Since then further options have presented themselves to the Board and are also under active review. The Directors continue to have reasonable expectations of securing funding which will enable the Group to meet its debt repayment, development programme and working capital requirements for a period in excess of twelve months.

 

Consequently, the financial statements have been prepared on a going concern basis. However, there can be no certainty that funding will be secured and this interim financial information does not contain any adjustments that might be necessary in the event that funding is not secured.

 

 

 

2. Investment Property valuations

 

At 30 June 2010 the Group's investment properties were valued at £31.1m (30.06.09 £49.4m) of which £3m (30.06.09 £26.8m) related to the UK portfolio and £28m (30.06.09 £22.6m) related to the German properties after conversion to sterling from Euros at an exchange rate of 1.2167 These values reflect the underlying position at 31 December 2009 uplifted for the completion of Adlershof 2 in the period.

 

 

3. Earnings per Share

Six months

Six months

Year

ended

ended

ended

30 June

30 June

31 December

2010

2009

2009

Basic earnings per share

Basic earnings per share is calculated by dividing the profit

attributable to equity holders of the Company by the weighted

average number of ordinary shares in issue during the year,

(Loss) / profit attributable to equity holders of the Company (£)

(2,022,988)

(905,825)

(1,903,049)

Weighted average number of ordinary shares in issue (thousands)

76,754

76,754

76,754

(Loss) / earnings per share (pence per share)

(2.64)

(0.09)

(2.48)

Diluted earnings per share

The Company has two categories of dilutive potential ordinary shares - share options and warrants. A calculation is

undertaken to determine the number of shares which could have been acquired at fair value based on the

monetary value of the subscription rights attached to outstanding share options. It is compared with the

number of shares which would have been issued assuming the exercise of the share options.

Six months

Six months

Year

ended

ended

ended

30 June

30 June

31 December

2010

2009

2009

(Loss) / profit attributable to equity holders of the Company (£)

(2,022,988)

(905,825)

(1,903,049)

Weighted average number of ordinary shares in issue (thousands)

76,754

76,754

76,754

Adjustment for share options (thousands)

-

-

-

Weighted average number of ordinary shares for diluted

earnings (thousands)

76,754

76,754

76,754

Diluted (Loss) / earnings per share (pence per share)

(2.64)

(0.09)

(2.48)

 

 

6. Availability of Results

 

These results are available on the Company's website, www.carecapital.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR KKADNQBKDKCB

Related Shares:

AVO.L
FTSE 100 Latest
Value8,809.74
Change53.53